R Angelo de Claro Selected Research

R Angelo de Claro Research Topics

Disease

4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 01/2020
3	Neoplasms (Cancer) 01/2023 - 12/2020
3	Fatigue 01/2022 - 01/2017
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 06/2011
2	Respiratory Tract Infections (Respiratory Tract Infection) 12/2019 - 01/2017
2	Diarrhea 12/2019 - 01/2017
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2019 - 01/2017
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 02/2011
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2019 - 11/2012
2	Hodgkin Disease (Hodgkin's Disease) 01/2017 - 11/2012
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2015 - 04/2015
1	Rare Diseases (Rare Disease) 12/2023
1	Leukemia 01/2023
1	Hypertension (High Blood Pressure) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	Pancreatitis 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Acute Promyelocytic Leukemia 11/2020
1	Second Primary Neoplasms (Neoplasms, Second) 11/2020
1	Mycosis Fungoides 12/2019
1	Infections 12/2019
1	Musculoskeletal Pain 12/2019
1	Exanthema (Rash) 12/2019
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2019
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019
1	Fever (Fevers) 01/2017
1	Cough 01/2017
1	Cytopenia 01/2017
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 08/2015
1	Lymphoma (Lymphomas) 04/2015
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2015
1	Inflammation (Inflammations) 06/2011
1	Atherosclerosis 06/2011
1	Sepsis (Septicemia) 02/2011

Drug/Important Bio-Agent (IBA)

3	Brentuximab VedotinIBA 01/2019 - 11/2012
2	Azacitidine (5 Azacytidine)FDA Link 11/2023 - 01/2022
2	ivosidenibIBA 11/2023 - 01/2020
2	TabletsIBA 01/2022 - 04/2015
2	NivolumabIBA 01/2021 - 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	cedazuridineIBA 01/2022
1	cc-486IBA 01/2022
1	decitabine and cedazuridine drug combinationIBA 01/2022
1	ponatinibIBA 01/2022
1	Decitabine FDA Link 01/2022
1	Cytidine DeaminaseIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	PlatinumIBA 01/2021
1	Anaplastic Lymphoma KinaseIBA 01/2021
1	IpilimumabIBA 01/2021
1	Arsenic Trioxide (Trisenox)FDA Link 11/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020
1	enasidenibIBA 01/2020
1	mogamulizumabIBA 12/2019
1	SteroidsIBA 12/2019
1	CCR ReceptorsIBA 12/2019
1	Prednisone (Sone)FDA LinkGeneric 01/2019
1	axicabtagene ciloleucelIBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Chimeric Antigen ReceptorsIBA 01/2019
1	Transaminases (Aminotransferases)IBA 01/2017
1	ibrutinibIBA 08/2015
1	idelalisibIBA 04/2015
1	Interleukin-10 (Interleukin 10)IBA 06/2011
1	LDL Receptors (LDL Receptor)IBA 06/2011
1	Interleukin-12 (IL 12)IBA 06/2011
1	Interleukin-6 (Interleukin 6)IBA 06/2011
1	Fas Ligand Protein (Fas Ligand)IBA 06/2011
1	Proteins (Proteins, Gene)FDA Link 02/2011

Therapy/Procedure

8	Therapeutics 01/2023 - 04/2015
3	Drug Therapy (Chemotherapy) 10/2022 - 11/2012
2	Hematopoietic Stem Cell Transplantation 12/2019 - 01/2017
1	Immunotherapy 12/2023
1	Induction Chemotherapy 01/2022
1	Transplantation 01/2017
1	Stem Cell Transplantation 11/2012
1	Ligation 02/2011
1	Punctures 02/2011